Home / Guides /
Daily pill or weekly shot
Is there a tirzepatide pill? GLP-1 pills vs. injections in 2026
By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated
There’s no FDA-approved tirzepatide pill as of November 1, 2026; Foundayo and the Wegovy pill are the FDA-approved
$139/mo on 12 months, every dosePrice Match Guarantee†
- Tirzepatide pill: none FDA-approved
GLP-1 pills for weight loss: Foundayo and Wegovy, $149 to $299 a month- Weekly shots: Zepbound $299 to $449 a month by dose ($449 from 7.5 mg needs a refill within 45 days; otherwise $499 to $699)
Pills vs. injections, in short
- A tirzepatide pill?
- Not an FDA-approved one
- FDA-approved
GLP-1 pills - Foundayo and the Wegovy pill, for weight loss. Rybelsus and Ozempic tablets are for type 2 diabetes; for weight loss they’d be off-label
- Pill prices
- $149 to $299 a month by dose
- Weekly injections
- Zepbound $299 to $449 ($449 from 7.5 mg needs a refill within 45 days; otherwise $499 to $699); NexLife $139 on 12 months, or $169 month to month
- Compounded tablets
- NexLife: compounded tirzepatide, $199 a month on 12 months or $229 month to month; semaglutide $165 on 12 months or $199 month to month; not FDA-approved
Not sure which fits your routine? Call or text
4.8 out of 5 on Trustpilot · LegitScript certified
About 3 minutes of health questions. No insurance needed.
Compounded medicines aren’t FDA-approved. A NexLife provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine.
At a glance
GLP-1 pill or weekly shot: approvals and prices at a glance
Self-pay prices from each company’s own site, checked November 1, 2026.
| Question | Answer |
|---|---|
| Is there a tirzepatide pill? | Not an FDA-approved one, as of November 1, 2026. Tirzepatide is approved only as a weekly injection: Zepbound or Mounjaro. |
| Is Foundayo tirzepatide? | No. It’s orforglipron, Lilly’s once-a-day pill, approved April 1, 2026. |
| What do the pills cost? | $149 to $299 a month by dose, self-pay, for Foundayo or the Wegovy pill. |
| What do weekly shots cost? | Zepbound: $299 to $449 by dose (at 7.5 to 15 mg, the $449 price needs a refill within 45 days, otherwise $499 to $699). Wegovy pen: $349 after $199 for each of a new patient’s first two fills (through December 31, 2026), $399 at 7.2 mg. |
| Are compounded tablets approved? | No. At NexLife, compounded tirzepatide tablets are $199 a month on the 12-month plan, or $229 month to month. |
| Compounded shots at NexLife? | Tirzepatide: $139 a month on the 12-month plan, or $169 month to month, at every dose. |
- Tell us about you About 3 minutes of health questions
- A licensed provider decides You’re prescribed only if it’s right for you
- Your partner pharmacy ships Usually within 1 to 2 business days, free
Key takeaways
- No tirzepatide pill is FDA-approved as of November 1, 2026: tirzepatide is approved only as a weekly injection, Zepbound or Mounjaro.
- Two
GLP-1 pills are FDA-approved for weight loss: Lilly’s Foundayo (orforglipron) and the Wegovy pill, each taken once a day. - Pills cost $149 to $299 a month by dose, self-pay, for Foundayo or the Wegovy pill (checked November 1, 2026).
- Daily pill or weekly shot: the Wegovy pill has food and water rules; Lilly says Foundayo doesn’t.
- Compounded tirzepatide tablets dissolve under the tongue. They aren’t FDA-approved, and there’s little published research on how well they’re absorbed.
- At NexLife, on the 12-month plan: compounded tirzepatide tablets are $199 a month at every dose; weekly shots are $139.
The short answer
Is there a tirzepatide pill?
Not an FDA-approved one. Tirzepatide is approved only as an injection: Zepbound for weight loss and Mounjaro for type 2 diabetes.
Foundayo isn’t tirzepatide. It’s orforglipron, a different medicine from Lilly, approved April 1, 2026 as a once-a-day pill.
“Foundayo is a glucagon-like peptide-1 (GLP-1) receptor agonist in tablet form that should be taken orally once daily.”
U.S. Food and Drug Administration, FDA Approves First New Molecular Entity Under National Priority Voucher Program
Compounded tablets exist. Some programs, NexLife included, offer compounded tirzepatide tablets that dissolve under the tongue ($199 a month on a 12-month plan at NexLife, or $229 month to month, at every dose). They aren’t FDA-approved, and there’s little published research on how well tirzepatide is absorbed that way. There’s a semaglutide version too: sublingual semaglutide tablets are $165 a month on a 12-month plan at NexLife, or $199 month to month, at every dose.
“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.”
U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers
Your options
Which GLP-1 pills and injections can you get, and what do they cost?
| Option | How you take it | FDA-approved? | Monthly price |
|---|---|---|---|
| Foundayo (orforglipron), Lilly | Pill, once a day | Yes | $149 to $299 by dose (LillyDirect) |
| Wegovy pill (semaglutide), Novo Nordisk | Pill, once a day | Yes | $149 at 1.5 mg, $199 at 4 mg, $299 at 9 and 25 mg |
| Zepbound (tirzepatide), Lilly | Injection, once a week | Yes | $299 to $449 by dose (LillyDirect; $449 from 7.5 mg needs a refill within 45 days, otherwise $499 to $699) |
| Wegovy pen (semaglutide), Novo Nordisk | Injection, once a week | Yes | $199 for each of a new patient’s first two fills (through December 31, 2026), then $349 ($399 at 7.2 mg) |
| Compounded tirzepatide at NexLife | Injection, once a week | No | $139 on a 12-month plan, $169 month to month, at every dose Pay less elsewhere? Matched† |
| Compounded semaglutide at NexLife | Injection, once a week | No | $119 on a 12-month plan, $139 month to month, at every dose Pay less elsewhere? Matched† |
| Compounded tablets at NexLife | Dissolves under the tongue | No | $199 tirzepatide and $165 semaglutide on a 12-month plan; $229 and $199 month to month, at every dose |
From each company’s own website, checked November 1, 2026. Your prescriber decides which one fits you.
Daily pill or weekly shot: how do you choose?
There’s no single right answer. It comes down to your routine, what you’ll pay at your dose and what your provider advises.
- More choices. Two
GLP-1 pills approved for weight loss now sit beside weekly injections. - Prices climb. Pill prices rise with the dose, to $299 a month.
- Routines differ. A daily pill and a weekly injection ask different things of you.
One weekly injection, one price at every dose.
- A licensed provider decides. A licensed provider reviews your history and what fits your routine.
- One flat price. $139 for tirzepatide and $119 for semaglutide on 12 months, or $169 and $139 month to month, at every dose.
- Care included. A nutrition plan and a coaching call, with no membership.
Real people, real answers. Call or text
Check my eligibilityCompounded, not FDA-approved: a licensed provider prescribes it only when it offers a significant difference for you.
Day to day
How is a GLP-1 pill different from a shot?
How often. Foundayo and the Wegovy pill are daily. Zepbound, the Wegovy pen and compounded injections are weekly.
Food and water. The Wegovy pill comes with rules about food and water. Lilly says Foundayo can be taken any time of day, without them.
“…a GLP-1 receptor partial agonist pill which does not need to be taken on an empty stomach”
Tracy Beth Høeg, M.D., Ph.D., acting director of the FDA’s Center for Drug Evaluation and Research, FDA Approves First New Molecular Entity Under National Priority Voucher Program
What it costs. Pills start at $149 a month and reach $299 at higher doses. Compounded injections at NexLife stay the same at every dose: $139 or $119 a month on 12-month plans, $169 or $139 month to month.
With insurance. Lilly says people with commercial insurance that covers Foundayo or Zepbound may pay as little as $25 a month.
With Medicare. From July 1, 2026, to December 31, 2027, Medicare’s
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
Centers for Medicare & Medicaid Services, Weight loss drugs
Before you choose
What should you ask your provider about GLP-1 pills vs. shots?
Which medicine fits my health history?
Your provider weighs your history, your other medicines and your goals.
Daily pill or weekly shot?
A routine you can keep matters as much as the medicine.
What will I pay at my maintenance dose?
Starting prices often rise with the dose, so the price at the dose you’ll stay on is the one that counts.
Step by step
How do you choose between a GLP-1 pill and an injection?
Start with what the FDA has approved, then weigh your routine, the trial results and the price at your dose, with your provider.
- Know what’s FDA-approved. There’s no FDA-approved tirzepatide pill as of November 1, 2026; tirzepatide is approved only as a weekly injection, Zepbound or Mounjaro. The FDA-approved GLP-1 pills for weight loss are Foundayo and the Wegovy pill.
- Pick a routine you can keep. Foundayo and the Wegovy pill are daily; Zepbound, the Wegovy pen and compounded injections are weekly. The Wegovy pill comes with food and water rules; Lilly says Foundayo can be taken any time of day.
- Compare the trial results. In separate trials, the pills led to less weight loss than Zepbound and a little less than the Wegovy shot. They weren’t head to head, and compounded versions weren’t studied.
- Compare the price at your dose. Self-pay, the pills run $149 to $299 a month by dose, and Zepbound $299 to $449; its $449 from 7.5 mg needs a refill within 45 days, or it’s $499 to $699. Ask what you’d pay at the dose you’ll stay on.
- Know what compounded tablets are. Compounded tirzepatide tablets dissolve under the tongue; they aren’t FDA-approved, with little published research on absorption. At NexLife: $199 a month on the 12-month plan, or $229 month to month; weekly shots are $139 and $169 on the same plans.
- Let your provider decide. Your provider weighs your history, your other medicines and your goals, then decides the medicine and the starting dose. Moving from a shot to a pill is a new prescription.
Prices were checked November 1, 2026, and your provider decides which medicine and which form fit you.
Vial math
How many units is your tirzepatide or semaglutide dose?
On a compounded vial, the units depend on its strength. Here are the label doses at example strengths, with the math to check your own.
Tirzepatide
| Dose | mL at 25 mg/mL | Units (U-100) | On the label |
|---|---|---|---|
| 2.5 mg | 0.1 mL | 10 units | Starting dose, for 4 weeks |
| 5 mg | 0.2 mL | 20 units | A maintenance dose |
| 7.5 mg | 0.3 mL | 30 units | A step up |
| 10 mg | 0.4 mL | 40 units | A maintenance dose |
| 12.5 mg | 0.5 mL | 50 units | A step up |
| 15 mg | 0.6 mL | 60 units | The maximum, and a maintenance dose |
The math: mL = dose ÷ strength (mg per mL), and units = mL × 100. At 25 mg/mL, 10 mg is 10 ÷ 25 = 0.4 mL, or 40 units.
Semaglutide
| Weeks | Weekly dose | At 2.5 mg/mL | At 5 mg/mL |
|---|---|---|---|
| 1 to 4 | 0.25 mg | 0.1 mL (10 units) | 0.05 mL (5 units) |
| 5 to 8 | 0.5 mg | 0.2 mL (20 units) | 0.1 mL (10 units) |
| 9 to 12 | 1 mg | 0.4 mL (40 units) | 0.2 mL (20 units) |
| 13 to 16 | 1.7 mg | 0.68 mL (68 units) | 0.34 mL (34 units) |
| 17 onward | 2.4 mg | 0.96 mL (96 units) | 0.48 mL (48 units) |
The math: mL = dose ÷ strength (mg per mL); units = mL × 100. At 2.5 mg/mL, 1 mg is 1 ÷ 2.5 = 0.4 mL, or 40 units. At 5 mg/mL, the same 1 mg is 0.2 mL, or 20 units.
25 mg per mL is an example only: it’s the strength of the 15 mg multi-dose vial on Zepbound’s label (15 mg per 0.6 mL). Read the strength on your own vial’s label; your provider sets your dose, in steps at least 4 weeks apart. Every step: the tirzepatide dosage chart. Both strengths are examples only. The same dose is a different number of units at a different strength, so read the strength on your own vial’s label. Your prescription sets your dose and schedule, which may differ from these label steps. Every step: the semaglutide dosage chart.
What would you pay with NexLife?
Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.
Pick one above to see your price.
Prices from each provider’s own site, checked November 1, 2026. Brand-name and compounded medications are different products: compounded medications aren’t FDA-approved, and a provider prescribes one only when it offers a significant difference for you. Price Match Guarantee† terms apply.
What does NexLife cost?
One flat price at every dose.
No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†
GIP + 12-month plan $139/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.
Check my eligibilityCompounded, not FDA-approved · Not prescribed? No charge for medication
12-month plan $119/mo
Semaglutide
Weekly
Compounded, not FDA-approved · Not prescribed? No charge for medication
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms
The NexLife Price Match Guarantee†
Paying less elsewhere?
Keep your price. Upgrade your care.
Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.
Pills vs. injections: your questions
Fair questions about NexLife
- Will my price go up with my dose?
- No. You pay the same at every dose.
- What if I’m not prescribed?
- You aren’t charged for medication.
- Can I cancel?
- Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
- Do I need insurance?
- No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.
Does tirzepatide come in pill form?
Not as an FDA-approved medicine, as of November 1, 2026: tirzepatide is approved only as a weekly injection, sold as Zepbound and Mounjaro. Some programs offer compounded tirzepatide tablets that dissolve under the tongue; they aren’t FDA-approved. At NexLife, they’re $199 a month on the 12-month plan, or $229 month to month.
Is Foundayo tirzepatide?
No. Foundayo is orforglipron, a different medicine from Lilly: a once-daily pill the FDA approved on April 1, 2026, for weight loss. Tirzepatide is approved only as a weekly injection, sold as Zepbound and Mounjaro. Foundayo costs $149 to $299 a month by dose, self-pay through LillyDirect (checked November 1, 2026).
How much is Foundayo without insurance?
$149 to $299 a month by dose, self-pay through LillyDirect (checked November 1, 2026): $149 at 0.8 and 2.5 mg, $199 at 5.5 mg, $299 from 9 to 17.2 mg. The 2.5 and 5.5 mg prices are reduced through December 31, 2026. With commercial insurance that covers it, Lilly says you may pay as little as $25.
How much is the Wegovy pill?
$149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg, self-pay through NovoCare (checked November 1, 2026). It’s a daily pill with rules about food and water. The Wegovy pen, the weekly shot, is $349 a month ($399 at 7.2 mg) after $199 for each of a new patient’s first two fills (through December 31, 2026).
Which is cheaper, a GLP-1 pill or an injection?
It depends on the dose. Self-pay, checked November 1, 2026: Foundayo and the Wegovy pill, $149 to $299 a month; Zepbound, $299 to $449 ($449 from 7.5 mg needs a refill within 45 days, otherwise $499 to $699); the Wegovy pen, $349 after $199 for each of a new patient’s first two fills (through December 31, 2026), $399 at 7.2 mg. At NexLife, compounded tirzepatide is $139 a month on the 12-month plan.
Can I switch from injections to a pill?
Possibly. It’s a new prescription, and your provider decides the medicine and the starting dose. Your routine changes too: Foundayo and the Wegovy pill are daily, while Zepbound, the Wegovy pen and compounded injections are weekly. The Wegovy pill also comes with rules about food and water.
Do GLP-1 pills work as well as shots?
In separate trials, the pills led to less weight loss than Zepbound and a little less than the Wegovy shot: 13.6% on the 25 mg Wegovy pill (OASIS 4), 11.1% on Foundayo (ATTAIN-1), 20.9% on Zepbound 15 mg (SURMOUNT-1) and 14.9% on the 2.4 mg Wegovy shot (STEP 1). These averages are for the FDA-approved medicines; compounded versions weren’t studied.
Does sublingual tirzepatide work as well as the shot?
No one knows yet. There’s little published research on how well tirzepatide is absorbed under the tongue, and Zepbound’s trial results came from weekly injections. Compounded tablets aren’t FDA-approved, and your provider can tell you whether a tablet or a weekly shot fits you better.
What is tirzepatide ODT?
An orally disintegrating tablet: a compounded tirzepatide tablet that dissolves under the tongue instead of a weekly shot. It isn’t FDA-approved, and research on how well tirzepatide is absorbed this way is limited. At NexLife it’s $199 a month on a 12-month plan, or $229 month to month, at every dose.
How much are compounded tirzepatide tablets?
Raeliva lists its tablets at $359 month to month, and Henry Meds at $1,047 for a 3-month supply (checked November 1, 2026). At NexLife they’re $199 a month on the 12-month plan, or $229 month to month, at every dose: $60 more than its weekly shots. Compounded tablets aren’t FDA-approved.
Do you have to take Foundayo on an empty stomach?
No. Lilly says Foundayo can be taken any time of day, without the food and water rules the Wegovy pill has. The FDA describes it as a pill that does not need to be taken on an empty stomach.
Does Medicare cover GLP-1 pills?
Yes, if you qualify. From July 1, 2026, to December 31, 2027, Medicare’s GLP-1 Bridge covers Foundayo, the Wegovy pill or injection and the Zepbound KwikPen for eligible Part D enrollees. You pay a $50 copay for each month’s supply.
Are Rybelsus and Ozempic tablets approved for weight loss?
No. Rybelsus and Ozempic tablets are for type 2 diabetes, so taking them for weight loss would be off-label. The FDA-approved GLP-1 pills for weight loss are Lilly’s Foundayo and the Wegovy pill, each taken once a day.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.
“No. A generic drug is approved by FDA under 505(j) of the FD&C Act and meets all of the requirements of that section (including establishing therapeutic equivalence to a brand name drug, among others), while a compounded drug is not approved by FDA.”
Who wrote and medically reviewed this page?
Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.
Foundayo’s approval and LillyDirect price, the Wegovy pill’s and pen’s NovoCare prices, Zepbound’s LillyDirect prices and NexLife’s injection and tablet prices checked November 1, 2026.
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
Paying less elsewhere? We match it.†
One weekly shot. One price at every dose.
Start online in about 3 minutes. A licensed provider decides what fits you.
4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
- 1Tell us about you
Start online with your health history.
- 2A licensed provider decides
Online, following your state’s rules. You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.
Sources
- Eli Lilly and Company. FDA approves Lilly’s Foundayo (orforglipron), news release (April 1, 2026).
- Eli Lilly and Company. Foundayo through LillyDirect.
- Eli Lilly and Company. Zepbound through LillyDirect.
- Novo Nordisk. What to pay for Wegovy.
- Novo Nordisk. Wegovy (semaglutide) prescribing information.
- U.S. Food and Drug Administration. FDA’s concerns with unapproved
GLP-1 drugs used for weight loss. - NexLife. Compounded tirzepatide plans.
- NexLife. Sublingual tirzepatide tablets.
- NexLife. Sublingual semaglutide tablets.
- Eli Lilly and Company. Zepbound (tirzepatide) prescribing information.
- LegitScript. LegitScript certification record for NexLife.us.
- NexLife. Compounded semaglutide plans.
- Ro: weight loss program pricing. Checked November 1, 2026.
- Hims: Zepbound KwikPen. Checked November 1, 2026.
- Hims: Wegovy pill and pen, with membership. Checked November 1, 2026.
- Mochi Health: FAQs (membership and medication prices). Checked November 1, 2026.
- Embody: compounded tirzepatide, one-month supply. Checked November 1, 2026.
- Embody: compounded semaglutide, one-month supply. Checked November 1, 2026.
- Raeliva: compounded tirzepatide oral dissolving tablets. Checked November 1, 2026.
- Henry Meds: programs and prices. Checked November 1, 2026.
- Drugs.com: Tirzepatide (dosage forms and brand names; updated September 30, 2026). Checked November 1, 2026: injection only (Zepbound, Zepbound KwikPen, Mounjaro, Mounjaro KwikPen).
- Novo Nordisk: Ozempic tablets and Rybelsus (semaglutide) tablets, prescribing information (revised January 2026). Read November 1, 2026.
- U.S. Food and Drug Administration. FDA Approves First New Molecular Entity Under National Priority Voucher Program. April 1, 2026.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
- Centers for Medicare & Medicaid Services. Weight loss drugs (Medicare.gov). Read November 2, 2026.
- Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge. Read November 2, 2026.